{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:50:21Z","timestamp":1793659821755,"version":"4.5.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ICES"},{"DOI":"10.13039\/501100020977","name":"Canadian Frailty Network","doi-asserted-by":"publisher","award":["CFN-006"],"award-info":[{"award-number":["CFN-006"]}],"id":[{"id":"10.13039\/501100020977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mortality risk following COVID-19 diagnosis in men and women with common comorbidities at different ages has been difficult to communicate to the general public. The purpose of this study was to determine the age at which unvaccinated men and women with common comorbidities have a mortality risk which exceeds that of 75- and 65-year-old individuals in the general population (Phases 1b\/1c thresholds of the Centre for Disease Control Vaccine Rollout Recommendations) following COVID-19 infection during the first wave.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a population-based retrospective cohort study using linked administrative datasets in Ontario, Canada. We identified all community-dwelling adults diagnosed with COVID-19 between January 1 and October 31st, 2020. Exposures of interest were age (modelled using restricted cubic splines) and the following conditions: major cardiovascular disease (recent myocardial infarction or lifetime history of heart failure); 2) diabetes; 3) hypertension; 4) recent cancer; 5) chronic obstructive pulmonary disease; 6) Stages 4\/5 chronic kidney disease (CKD); 7) frailty. Logistic regression in the full cohort was used to estimate the risk of 30-day mortality for 75- and 65-year-old individuals. Analyses were repeated after stratifying by sex and medical condition to determine the age at which 30-day morality risk in strata exceed that of the general population at ages 65 and 75 years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We studied 52,429 individuals (median age 42 years; 52.5% women) of whom 417 (0.8%) died within 30 days. The 30-day mortality risk increased with age, male sex, and comorbidities. The 65- and 75-year-old mortality risks in the general population were exceeded at the youngest age by people with CKD, cancer, and frailty. Conversely, women aged\u2009&lt;\u200965 years who had diabetes or hypertension did not have higher mortality than 65-year-olds in the general population. Most people with medical conditions (except for Stage 4\u20135 CKD) aged\u2009&lt;\u200945 years had lower predicted mortality than the general population at age 65 years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The mortality risk in COVID-19 increases with age and comorbidity but the prognostic implications varied by sex and condition. These observations can support communication efforts and inform vaccine rollout in jurisdictions with limited vaccine supplies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-15386-4","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:03:48Z","timestamp":1678712628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Husam","family":"Abdel-Qadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Sivaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harindra C.","family":"Wijeysundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"8","key":"15386_CR1","doi-asserted-by":"publisher","first-page":"e0238215","DOI":"10.1371\/journal.pone.0238215","volume":"15","author":"P Ssentongo","year":"2020","unstructured":"Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS ONE. 2020;15(8):e0238215.","journal-title":"PLoS ONE"},{"key":"15386_CR2","doi-asserted-by":"crossref","unstructured":"Sanyaolu A, Okorie C, Marinkovic A et al. Comorbidity and its impact on patients with COVID-19.SN Compr Clin Med2020:1\u20138.","DOI":"10.1007\/s42399-020-00363-4"},{"issue":"5","key":"15386_CR3","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/ije\/dyaa140","volume":"49","author":"M Reilev","year":"2020","unstructured":"Reilev M, Kristensen KB, Potteg\u00e5rd A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468\u201381.","journal-title":"Int J Epidemiol"},{"issue":"14","key":"15386_CR4","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/ijerph17145171","volume":"17","author":"B Poblador-Plou","year":"2020","unstructured":"Poblador-Plou B, Carmona-P\u00edrez J, Ioakeim-Skoufa I, et al. Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain. Int J Environ Res Public Health. 2020;17(14):5171.","journal-title":"Int J Environ Res Public Health"},{"key":"15386_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.annepidem.2020.08.005","volume":"52","author":"GM Parra-Bracamonte","year":"2020","unstructured":"Parra-Bracamonte GM, Lopez-Villalobos N, Parra-Bracamonte FE. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Ann Epidemiol. 2020;52:93\u201398e2.","journal-title":"Ann Epidemiol"},{"issue":"12","key":"15386_CR6","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/clc.23465","volume":"43","author":"L Luo","year":"2020","unstructured":"Luo L, Fu M, Li Y, et al. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis. Clin Cardiol. 2020;43(12):1478\u201393.","journal-title":"Clin Cardiol"},{"issue":"4","key":"15386_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/joim.13119","volume":"288","author":"Z Imam","year":"2020","unstructured":"Imam Z, Odish F, Gill I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. 2020;288(4):469\u201376.","journal-title":"J Intern Med"},{"issue":"9","key":"15386_CR8","doi-asserted-by":"publisher","first-page":"e1003321","DOI":"10.1371\/journal.pmed.1003321","volume":"17","author":"SL Harrison","year":"2020","unstructured":"Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GY. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17(9):e1003321.","journal-title":"PLoS Med"},{"key":"15386_CR9","doi-asserted-by":"publisher","first-page":"m3731","DOI":"10.1136\/bmj.m3731","volume":"371","author":"AK Clift","year":"2020","unstructured":"Clift AK, Coupland CA, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731.","journal-title":"BMJ"},{"issue":"1","key":"15386_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"SI Cho","year":"2021","unstructured":"Cho SI, Yoon S, Lee H-J. Impact of comorbidity burden on mortality in patients with COVID-19 using the korean health insurance database. Sci Rep. 2021;11(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"1","key":"15386_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000512592","volume":"64","author":"M Biswas","year":"2021","unstructured":"Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2021;64(1):36\u201347.","journal-title":"Intervirology"},{"issue":"2","key":"15386_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ajic.2020.06.213","volume":"49","author":"KT Bajgain","year":"2021","unstructured":"Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: a rapid review of current literature. Am J Infection Control. 2021;49(2):238\u201346.","journal-title":"Am J Infection Control"},{"issue":"10278","key":"15386_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"OJ Wouters","year":"2021","unstructured":"Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023\u201334.","journal-title":"Lancet"},{"issue":"14","key":"15386_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1056\/NEJMp2103614","volume":"384","author":"IT Katz","year":"2021","unstructured":"Katz IT, Weintraub R, Bekker L-G, Brandt AM. From vaccine nationalism to vaccine equity\u2014finding a path forward. N Engl J Med. 2021;384(14):1281\u20133.","journal-title":"N Engl J Med"},{"issue":"7","key":"15386_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.chom.2021.06.007","volume":"29","author":"A Asundi","year":"2021","unstructured":"Asundi A, O\u2019Leary C, Bhadelia N. Global COVID-19 vaccine inequity: the scope, the impact, and the challenges. Cell Host Microbe. 2021;29(7):1036\u20139.","journal-title":"Cell Host Microbe"},{"key":"15386_CR16","doi-asserted-by":"publisher","first-page":"n3074","DOI":"10.1136\/bmj.n3074","volume":"375","author":"F Hassan","year":"2021","unstructured":"Hassan F, London L, Gonsalves G. Unequal global vaccine coverage is at the heart of the current covid-19 crisis. BMJ. 2021;375:n3074.","journal-title":"BMJ"},{"issue":"7","key":"15386_CR17","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1016\/S2214-109X(21)00140-6","volume":"9","author":"JH Kim","year":"2021","unstructured":"Kim JH, Hotez P, Batista C, et al. Operation Warp Speed: implications for global vaccine security. Lancet Glob Health. 2021;9(7):e1017\u201321.","journal-title":"Lancet Glob Health"},{"key":"15386_CR18","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.54724\/lc.2022.e10","volume":"2","author":"SY Kim","year":"2022","unstructured":"Kim SY, Yeniova A. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 dashboard. Life Cycle. 2022;2:e10.","journal-title":"Life Cycle"},{"key":"15386_CR19","unstructured":"Centers for Disease Control and Prevention. CDC\u2019s COVID-19 Vaccine Rollout Recommendations. Available online at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations.html. Accessed March 27, 2021."},{"key":"15386_CR20","unstructured":"Centers for Disease Control and Prevention. Certain Medical Conditions and Risk for Severe COVID-19 Illness. Available online at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html. Accessed on March 27, 2021."},{"issue":"1","key":"15386_CR21","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2214-109X(20)30464-2","volume":"9","author":"N Dehingia","year":"2021","unstructured":"Dehingia N, Raj A. Sex differences in COVID-19 case fatality: do we know enough? Lancet Glob Health. 2021;9(1):e14\u20135.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"15386_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09826-8","volume":"20","author":"ND Yanez","year":"2020","unstructured":"Yanez ND, Weiss NS, Romand J-A, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1):1\u20137.","journal-title":"BMC Public Health"},{"issue":"10250","key":"15386_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0140-6736(20)31748-7","volume":"396","author":"SS Bhopal","year":"2020","unstructured":"Bhopal SS, Bhopal R. Sex differential in COVID-19 mortality varies markedly by age. Lancet. 2020;396(10250):532\u20133.","journal-title":"Lancet"},{"issue":"20","key":"15386_CR24","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"10","key":"15386_CR25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345\u201355.","journal-title":"JAMA Intern Med"},{"issue":"10229","key":"15386_CR26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"5","key":"15386_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s42256-020-0180-7","volume":"2","author":"L Yan","year":"2020","unstructured":"Yan L, Zhang H-T, Goncalves J, et al. An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell. 2020;2(5):283\u20138.","journal-title":"Nat Mach Intell"},{"issue":"10","key":"15386_CR28","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1016\/S2589-7500(20)30217-X","volume":"2","author":"AS Yadaw","year":"2020","unstructured":"Yadaw AS, Yan-Chak L, Bose S, Iyengar R, Bunyavanich S, Pandey G. Clinical features of COVID-19 mortality: development and validation of a clinical prediction model. Lancet Digit Health. 2020;2(10):e516\u201325.","journal-title":"Lancet Digit Health"},{"issue":"7","key":"15386_CR29","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1016\/S2589-7500(21)00080-7","volume":"3","author":"V Nafilyan","year":"2021","unstructured":"Nafilyan V, Humberstone B, Mehta N, et al. An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England. Lancet Digit Health. 2021;3(7):e425\u201333.","journal-title":"Lancet Digit Health"},{"key":"15386_CR30","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4\u00a0C mortality score. BMJ. 2020;370:m3339.","journal-title":"BMJ"},{"issue":"1","key":"15386_CR31","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1038\/s41598-021-81844-x","volume":"11","author":"E Jimenez-Solem","year":"2021","unstructured":"Jimenez-Solem E, Petersen TS, Hansen C, et al. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national european cohort of 5594 patients. Sci Rep. 2021;11(1):3246.","journal-title":"Sci Rep"},{"issue":"1","key":"15386_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18684-2","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, Cai G-Y, Fang W, et al. Machine learning based early warning system enables accurate mortality risk prediction for COVID-19. Nat Commun. 2020;11(1):1\u201310.","journal-title":"Nat Commun"},{"issue":"1","key":"15386_CR33","doi-asserted-by":"publisher","first-page":"e29872","DOI":"10.2196\/29872","volume":"8","author":"R Tsai","year":"2022","unstructured":"Tsai R, Hervey J, Hoffman K, et al. COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, and other serious comorbid conditions: cross-sectional, internet-based survey. JMIR Public Health Surveill. 2022;8(1):e29872.","journal-title":"JMIR Public Health Surveill"},{"issue":"7","key":"15386_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/vaccines9070767","volume":"9","author":"E Savoia","year":"2021","unstructured":"Savoia E, Piltch-Loeb R, Goldberg B, et al. Predictors of COVID-19 vaccine hesitancy: socio-demographics, co-morbidity, and past experience of racial discrimination. Vaccines (Basel). 2021;9(7):767.","journal-title":"Vaccines (Basel)"},{"key":"15386_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2021.03.008","volume":"94","author":"E Robertson","year":"2021","unstructured":"Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41\u201350.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"15386_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00520-021-06419-y","volume":"30","author":"N Mejri","year":"2022","unstructured":"Mejri N, Berrazega Y, Ouertani E, et al. Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients. Support Care Cancer. 2022;30(1):289\u201393.","journal-title":"Support Care Cancer"},{"issue":"6","key":"15386_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/MLR.0000000000000544","volume":"54","author":"WK Bleser","year":"2016","unstructured":"Bleser WK, Miranda PY, Jean-Jacques M. Racial\/ethnic disparities in influenza vaccination of chronically-ill us adults: the mediating role of perceived discrimination in healthcare. Med Care. 2016;54(6):570.","journal-title":"Med Care"},{"issue":"7","key":"15386_CR38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamainternmed.2021.1445","volume":"181","author":"K Grumbach","year":"2021","unstructured":"Grumbach K, Judson T, Desai M, et al. Association of race\/ethnicity with likeliness of COVID-19 vaccine uptake among health workers and the general population in the San Francisco Bay Area. JAMA Intern Med. 2021;181(7):1008\u201311.","journal-title":"JAMA Intern Med"},{"key":"15386_CR39","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.eclinm.2020.100495","volume":"26","author":"AA Malik","year":"2020","unstructured":"Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"15386_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jama.2020.26419","volume":"325","author":"PG Szilagyi","year":"2021","unstructured":"Szilagyi PG, Thomas K, Shah MD, et al. National trends in the US public\u2019s likelihood of getting a COVID-19 vaccine\u2014April 1 to December 8, 2020. JAMA. 2021;325(4):396\u20138.","journal-title":"JAMA"},{"issue":"3","key":"15386_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/obhd.1994.1091","volume":"60","author":"ER Stone","year":"1994","unstructured":"Stone ER, Yates JF, Parker AM. Risk communication: absolute versus relative expressions of low-probability risks. Organ Behav Hum Decis Process. 1994;60(3):387\u2013408.","journal-title":"Organ Behav Hum Decis Process"},{"issue":"1","key":"15386_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/jama.289.1.95","volume":"289","author":"RJ Gordon-Lubitz","year":"2003","unstructured":"Gordon-Lubitz RJ. Risk communication: problems of presentation and understanding. JAMA. 2003;289(1):95\u20135.","journal-title":"JAMA"},{"issue":"suppl 1","key":"15386_CR43","doi-asserted-by":"publisher","first-page":"i9","DOI":"10.1136\/qhc.0100009","volume":"10","author":"A Edwards","year":"2001","unstructured":"Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care. 2001;10(suppl 1):i9\u2013i13.","journal-title":"Qual Health Care"},{"key":"15386_CR44","unstructured":"Freemen A. The strange world of risk perception, and communicating risks. 2020. Available online at: https:\/\/blogs.bmj.com\/bmj\/2020\/11\/18\/alexandra-freeman-the-strange-world-of-risk-perception-and-communicating-risks\/. Accessed December 4, 2021."},{"issue":"19","key":"15386_CR45","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/jnci\/djr318","volume":"103","author":"A Fagerlin","year":"2011","unstructured":"Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011;103(19):1436\u201343.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"15386_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-018-0760-1","volume":"18","author":"C Bonner","year":"2018","unstructured":"Bonner C, Bell K, Jansen J, et al. Should heart age calculators be used alongside absolute cardiovascular disease risk assessment? BMC Cardiovasc Disord. 2018;18(1):1\u20138.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"15386_CR47","doi-asserted-by":"publisher","first-page":"e19028","DOI":"10.2196\/19028","volume":"22","author":"C Bonner","year":"2020","unstructured":"Bonner C, Raffoul N, Battaglia T, Mitchell JA, Batcup C, Stavreski B. Experiences of a national web-based heart age calculator for cardiovascular disease prevention: user characteristics, heart age results, and behavior change survey. J Med Internet Res. 2020;22(8):e19028.","journal-title":"J Med Internet Res"},{"issue":"8","key":"15386_CR48","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.pec.2018.03.015","volume":"101","author":"OC Damman","year":"2018","unstructured":"Damman OC, Vonk SI, Van den Haak MJ, van Hooijdonk CM, Timmermans DR. The effects of infographics and several quantitative versus qualitative formats for cardiovascular disease risk, including heart age, on people\u2019s risk understanding. Patient Educ Couns. 2018;101(8):1410\u20138.","journal-title":"Patient Educ Couns"},{"issue":"3","key":"15386_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/2047487313518479","volume":"22","author":"AA Lopez-Gonzalez","year":"2015","unstructured":"Lopez-Gonzalez AA, Aguilo A, Frontera M, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a southern european population: a randomized trial. Eur J Prev Cardiol. 2015;22(3):389\u201396.","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"15386_CR50","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1111\/jgs.17425","volume":"69","author":"DS Lee","year":"2021","unstructured":"Lee DS, Ma S, Chu A, et al. Predictors of mortality among long-term care residents with SARS-CoV-2 infection. J Am Geriatr Soc. 2021;69(12):3377\u201388.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"15386_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jclinepi.2006.12.009","volume":"60","author":"MJ Vermeulen","year":"2007","unstructured":"Vermeulen MJ, Tu JV, Schull MJ. ICD-10 adaptations of the Ontario Acute Myocardial Infarction Mortality Prediction Rules performed as well as the original versions. J Clin Epidemiol. 2007;60(9):971\u20134.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"15386_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.24095\/hpcdp.33.3.06","volume":"33","author":"SE Schultz","year":"2013","unstructured":"Schultz SE, Rothwell DM, Chen Z, Tu K. Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can. 2013;33(3):160\u20136.","journal-title":"Chronic Dis Inj Can"},{"issue":"1","key":"15386_CR53","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12913-018-3148-0","volume":"18","author":"LL Lipscombe","year":"2018","unstructured":"Lipscombe LL, Hwee J, Webster L, Shah BR, Booth GL, Tu K. Identifying diabetes cases from administrative data: a population-based validation study. BMC Health Serv Res. 2018;18(1):316.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"15386_CR54","first-page":"e18","volume":"1","author":"K Tu","year":"2007","unstructured":"Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA. Accuracy of administrative databases in identifying patients with hypertension. Open Med. 2007;1(1):e18\u2013e26.","journal-title":"Open Med"},{"issue":"5","key":"15386_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0895-4356(88)90052-2","volume":"41","author":"SC Robles","year":"1988","unstructured":"Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495\u2013501.","journal-title":"J Clin Epidemiol"},{"issue":"9795","key":"15386_CR56","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(11)60990-2","volume":"378","author":"AS Gershon","year":"2011","unstructured":"Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991\u20136.","journal-title":"Lancet"},{"key":"15386_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2369-14-81","volume":"14","author":"JL Fleet","year":"2013","unstructured":"Fleet JL, Dixon SN, Shariff SZ, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81.","journal-title":"BMC Nephrol"},{"key":"15386_CR58","unstructured":"Abrams C, Lieberman R, Weiner JP. Development and evaluation of the Johns Hopkins University risk adjustment models for Medicare + Choice plan payment. Final report to Centers for Medicare and Medicaid Services, US Department of Health and Human Services. Baltimore, MD, USA: Johns Hopkins University. Published June 6, 2003."},{"issue":"2","key":"15386_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/jcm9020523","volume":"9","author":"S-M Jung","year":"2020","unstructured":"Jung S-M, Akhmetzhanov AR, Hayashi K, et al. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases. J Clin Med. 2020;9(2):523.","journal-title":"J Clin Med"},{"issue":"20","key":"15386_CR60","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.3390\/ijerph17207560","volume":"17","author":"C Faes","year":"2020","unstructured":"Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N. Time between symptom onset, hospitalisation and recovery or death: statistical analysis of belgian COVID-19 patients. Int J Environ Res Public Health. 2020;17(20):7560.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"15386_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27\u201338.","journal-title":"Biometrika"},{"issue":"18","key":"15386_CR62","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.106.682658","volume":"117","author":"MP LaValley","year":"2008","unstructured":"LaValley MP, Logistic, Regression. Circulation. 2008;117(18):2395\u20139.","journal-title":"Circulation"},{"key":"15386_CR63","doi-asserted-by":"crossref","unstructured":"Harrell FE. Regression modeling strategies: with applications to Linear Models, logistic and ordinal regression, and Survival Analysis. Springer International Publishing; 2015.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"7675","key":"15386_CR64","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature24265","volume":"550","author":"T Tukiainen","year":"2017","unstructured":"Tukiainen T, Villani AC, Yen A, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550(7675):244\u20138.","journal-title":"Nature"},{"issue":"4","key":"15386_CR65","doi-asserted-by":"publisher","first-page":"e214347","DOI":"10.1001\/jamanetworkopen.2021.4347","volume":"4","author":"GN Ioannou","year":"2021","unstructured":"Ioannou GN, Green P, Fan VS, et al. Development of COVIDVax model to estimate the risk of SARS-CoV-2\u2013related death among 7.6 million US veterans for use in vaccination prioritization. JAMA Netw Open. 2021;4(4):e214347\u20137.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"15386_CR66","doi-asserted-by":"publisher","first-page":"201199","DOI":"10.1098\/rsos.201199","volume":"7","author":"J Roozenbeek","year":"2020","unstructured":"Roozenbeek J, Schneider CR, Dryhurst S, et al. Susceptibility to misinformation about COVID-19 around the world. R Soc Open Sci. 2020;7(10):201199.","journal-title":"R Soc Open Sci"},{"issue":"4","key":"15386_CR67","doi-asserted-by":"publisher","first-page":"e21071","DOI":"10.2196\/21071","volume":"6","author":"SH Ali","year":"2020","unstructured":"Ali SH, Foreman J, Tozan Y, Capasso A, Jones AM, DiClemente RJ. Trends and predictors of COVID-19 information sources and their relationship with knowledge and beliefs related to the pandemic: nationwide cross-sectional study. JMIR Public Health Surveill. 2020;6(4):e21071.","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"15386_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0272989X17729359","volume":"38","author":"D Petrova","year":"2018","unstructured":"Petrova D, Kostopoulou O, Delaney BC, Cokely ET, Garcia-Retamero R. Strengths and gaps in physicians\u2019 risk communication: a scenario study of the influence of numeracy on cancer screening communication. Med Decis Making. 2018;38(3):355\u201365.","journal-title":"Med Decis Making"},{"key":"15386_CR69","doi-asserted-by":"crossref","unstructured":"Kurz-Milcke E, Gigerenzer G, Martignon L. Transparency in risk communication: graphical and analog tools.Ann N Y Acad Sci2008:18\u201328.","DOI":"10.1196\/annals.1399.004"},{"key":"15386_CR70","unstructured":"Centers for Disease Control and Prevention. COVID-19 Data Review: Update on COVID-19\u2013Related Mortality. Available online at https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/data-review\/index.html. Last updated Jan. 27, 2023. Accessed January 31, 2023."},{"key":"15386_CR71","doi-asserted-by":"publisher","first-page":"e070695","DOI":"10.1136\/bmj-2022-070695","volume":"378","author":"IL Ward","year":"2022","unstructured":"Ward IL, Bermingham C, Ayoubkhani D, et al. Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2): retrospective cohort study. BMJ. 2022;378:e070695.","journal-title":"BMJ"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-15386-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15386-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T14:07:18Z","timestamp":1678716438000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-15386-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["15386"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-15386-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ICES is an independent, non-profit research institute funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). As a prescribed entity under Ontario\u2019s Personal Health Information Protection Act (PHIPA), Sect.\u00a045 of PHIPA authorizes ICES to collect and use personal health information and health care data, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system Ontario\u2019s privacy legislation. Secure access to these data is governed by policies and procedures that are approved by the Information and Privacy Commissioner of Ontario. Projects that use data collected by ICES under Sect.\u00a045 of PHIPA, and use no other data, are exempt from Research Ethics Board review. The use of the data in this project is authorized under Sect.\u00a045 and approved by ICES\u2019 Privacy and Legal Office. All methods were carried out in accordance with locally relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HA is supported by a National New Investigator Award from the Heart and Stroke Foundation of Canada. PA was supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation of Ontario. DSL is supported by the Ted Rogers Chair in Heart Function Outcomes. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}